Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of John D’Amico as a ...

Block (XYZ) shares were in the spotlight on June 30 after Piper Sandler analyst Bill Carcache said they were significantly ...

CNBC's Kelly Evans discusses recent market action, earnings estimates and more with Michael Kantrowitz, chief investment ...

Darden Restaurants, Inc. (NYSE:DRI) will trade ex-dividend on July 10, putting it among the 10 Best July Dividend Stocks to ...

Detailed price information for Ascentage Pharma Group Intl ADR (AAPG-Q) from The Globe and Mail including charting and trades.

A push to rake in more revenue and lower its operating costs should give the company's shares a big bump, per Piper Sandler.

Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing neuro-ophthalmic and ophthalmic diseases with significant ...

Piper Sandler took actions on several payment and consumer finance stocks, having double upgraded Block (XYZ) and assigning a ...

Visa Inc. (NYSE:V) ranks among the best fintech stocks to buy as digital payments volume surges. On June 30, Piper Sandler ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. The stock-market sell-off has bottomed out, Piper Sandler strategist Michael Kantrowitz says.

Piper Sandler upgrades Synopsys (SNPS) to Overweight with $550 target, driven by Intel foundry momentum and potential Apple, ...

MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, will release its fourth quarter and full year 2025 financial results prior to the opening of the market ...